Ashley Grossman

Summary

Affiliation: Queen Mary
Country: UK

Publications

  1. ncbi Imaging in Cushing's syndrome
    Anju Sahdev
    Department of Diagnostic Imaging, St Bartholomew s Hospital, London, UK
    Arq Bras Endocrinol Metabol 51:1319-28. 2007
  2. ncbi Clinical Review#: The diagnosis and management of central hypoadrenalism
    Ashley B Grossman
    Barts and the London School of Medicine, London, United Kingdom
    J Clin Endocrinol Metab 95:4855-63. 2010
  3. ncbi Commentary: imaging of islet-cell tumours
    Ashley B Grossman
    Department of Endocrinology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK
    Best Pract Res Clin Endocrinol Metab 19:241-3. 2005
  4. ncbi Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?
    Ashley Grossman
    Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London, EC1A 7BE, UK, and Department of Medicine, University of Toronto, Ontario, Canada
    Ann N Y Acad Sci 1073:332-47. 2006
  5. ncbi Cushing's syndrome caused by an occult source: difficulties in diagnosis and management
    Ashley B Grossman
    Centre for Endocrinology, St Bartholomew s Hospital, Bart s and The London Medical School, Queen Mary, University of London, UK
    Nat Clin Pract Endocrinol Metab 2:642-7. 2006
  6. ncbi Akting and cycling: a tale of the pituitary
    Ashley B Grossman
    Department of Endocrinology, St Bartholomew s Hospital, London, UK
    Horm Res 62:117-23. 2004
  7. ncbi Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor
    Blerina Kola
    Departments of Endocrinology and Histopatholgy, St Bartholomew s Hospital and National Institute of Neurology and Neurosurgery, London, UK
    Clin Endocrinol (Oxf) 59:328-38. 2003
  8. ncbi The molecular biology of pituitary tumors: a personal perspective
    Ashley B Grossman
    Department of Endocrinology, Centre for Endocrinology, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
    Pituitary 12:265-70. 2009
  9. ncbi Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease
    Helen L Storr
    Department of Endocrinology, St Bartholomew's Hospital, London, UK
    Eur J Endocrinol 152:825-33. 2005
  10. ncbi The role of somatostatin analogues in the treatment of neuroendocrine tumours
    Simona Grozinsky-Glasberg
    Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary School of Medicine, University of London, London, UK
    Mol Cell Endocrinol 286:238-50. 2008

Detail Information

Publications86

  1. ncbi Imaging in Cushing's syndrome
    Anju Sahdev
    Department of Diagnostic Imaging, St Bartholomew s Hospital, London, UK
    Arq Bras Endocrinol Metabol 51:1319-28. 2007
    ..MRI is used for characterising adrenal adenomas, problem solving in difficult cases and for detecting ACTH-secreting pituitary adenomas...
  2. ncbi Clinical Review#: The diagnosis and management of central hypoadrenalism
    Ashley B Grossman
    Barts and the London School of Medicine, London, United Kingdom
    J Clin Endocrinol Metab 95:4855-63. 2010
    ..It is essential to perform validated diagnostic procedures and manage such patients with clear objectives and based on well-established replacement programs...
  3. ncbi Commentary: imaging of islet-cell tumours
    Ashley B Grossman
    Department of Endocrinology, St Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK
    Best Pract Res Clin Endocrinol Metab 19:241-3. 2005
  4. ncbi Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?
    Ashley Grossman
    Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London, EC1A 7BE, UK, and Department of Medicine, University of Toronto, Ontario, Canada
    Ann N Y Acad Sci 1073:332-47. 2006
    ..This article summarizes the discussion and recommendations derived from that session...
  5. ncbi Cushing's syndrome caused by an occult source: difficulties in diagnosis and management
    Ashley B Grossman
    Centre for Endocrinology, St Bartholomew s Hospital, Bart s and The London Medical School, Queen Mary, University of London, UK
    Nat Clin Pract Endocrinol Metab 2:642-7. 2006
    ..She did not take tobacco, recreational drugs or alcohol. Upon physical examination she was grossly Cushingoid with florid clinical manifestations...
  6. ncbi Akting and cycling: a tale of the pituitary
    Ashley B Grossman
    Department of Endocrinology, St Bartholomew s Hospital, London, UK
    Horm Res 62:117-23. 2004
    ....
  7. ncbi Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor
    Blerina Kola
    Departments of Endocrinology and Histopatholgy, St Bartholomew s Hospital and National Institute of Neurology and Neurosurgery, London, UK
    Clin Endocrinol (Oxf) 59:328-38. 2003
    ..We hypothesized that the physiological IGF-I/GH negative feedback loop may be reset in somatotroph adenomas, specifically in terms of the level of expression of these receptors or mutations of the GH receptor (GH-R) in such tumours...
  8. ncbi The molecular biology of pituitary tumors: a personal perspective
    Ashley B Grossman
    Department of Endocrinology, Centre for Endocrinology, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
    Pituitary 12:265-70. 2009
    ..These pathways share a common root in the tyrosine kinase receptor, and a change to these receptors or their relationship to membrane matrix-related proteins may be an early event in tumorigenesis...
  9. ncbi Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease
    Helen L Storr
    Department of Endocrinology, St Bartholomew's Hospital, London, UK
    Eur J Endocrinol 152:825-33. 2005
    ....
  10. ncbi The role of somatostatin analogues in the treatment of neuroendocrine tumours
    Simona Grozinsky-Glasberg
    Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary School of Medicine, University of London, London, UK
    Mol Cell Endocrinol 286:238-50. 2008
    ..Development of new somatostatin analogues and new drug combination therapies should further improve the clinical management of these patients...
  11. ncbi Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity
    Maria Gueorguiev
    Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK
    Obesity (Silver Spring) 17:745-54. 2009
    ....
  12. ncbi A mutation and expression analysis of the oncogene BRAF in pituitary adenomas
    Iain Ewing
    Department of Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, UK
    Clin Endocrinol (Oxf) 66:348-52. 2007
    ..We speculated that this same gene may be either mutated at this site, or overexpressed, in pituitary adenomas...
  13. ncbi Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors
    Michel Procopiou
    Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London EC1A7BE, UK
    Eur J Endocrinol 161:131-40. 2009
    ..To define the test characteristics of an enzyme immunoassay (EIA) for plasma-free metanephrines (metanephrine and normetanephrine) in the diagnosis of pheochromocytoma and paraganglioma...
  14. ncbi Diagnosis and treatment of Cushing's disease in children
    Martin O Savage
    Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Barts and the Royal London NHS Trust, London, UK
    Endocr Dev 17:134-45. 2010
    ..The management of paediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
  15. ncbi PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor
    Michelle N Emery
    Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
    Clin Endocrinol (Oxf) 65:389-95. 2006
    ..CONCLUSIONS :Our data suggest that the antiproliferative action of rosiglitazone is probably not via PPAR-gamma...
  16. ncbi Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours
    Umasuthan Srirangalingam
    Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London EC1A 7BE, UK
    Endocr Relat Cancer 16:515-25. 2009
    ..VHL-related tumours tend to be adrenal phaeochromocytomas, frequently bilateral and associated with a milder phenotype...
  17. ncbi The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up
    Andrea M Isidori
    Department of Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 91:371-7. 2006
    ..These cases require a prolonged follow-up, review, and repetition of diagnostic tests and scans...
  18. ncbi Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients
    Amar Agha
    William Harvey Research Institute, Queen Mary University of London, London, UK
    Clin Endocrinol (Oxf) 66:72-7. 2007
    ..The effect of GH replacement on thyroid function in hypopituitary patients has hitherto been studied in small groups of children and adults with conflicting results...
  19. ncbi Work-up and management of paediatric Cushing's syndrome
    Martin O Savage
    Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, UK
    Curr Opin Endocrinol Diabetes Obes 15:346-51. 2008
    ..A protocol for investigation of the child with suspected Cushing's syndrome is presented followed by principles of management...
  20. ncbi Diagnosis and treatment of pediatric Cushing's disease
    Martin O Savage
    Department of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, UK
    Pituitary 10:365-71. 2007
    ..The management of pediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
  21. ncbi The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas
    Chrysanthia A Leontiou
    Department of Endocrinology, Barts and the London School of Medicine, London, United Kingdom
    J Clin Endocrinol Metab 93:2390-401. 2008
    ..Mutations have been identified in the aryl hydrocarbon receptor-interacting protein (AIP) gene in familial isolated pituitary adenomas (FIPA). It is not clear, however, how this molecular chaperone is involved in tumorigenesis...
  22. ncbi Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers
    Umasuthan Srirangalingam
    Department of Endocrinology, St Bartholomew s Hospital, West Smithfield, London, UK
    Clin Endocrinol (Oxf) 69:587-96. 2008
    ..The aim of this study was to describe the clinical manifestations of subjects with SDH-B gene mutations...
  23. ncbi Advances in the management of paediatric Cushing's disease
    Martin O Savage
    Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London, UK
    Horm Res 69:327-33. 2008
    ..The management of paediatric CD patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
  24. ncbi Pediatric Cushing's syndrome: clinical features, diagnosis, and treatment
    Li F Chan
    Department of Endocrinology, William Harvey Research Institute, St Bartholomew s and the Royal London School of Medicine and Dentistry
    Arq Bras Endocrinol Metabol 51:1261-71. 2007
    ..This article will aim to provide an overall view of pediatric CS highlighting some of the differences between adult and pediatric CS...
  25. ncbi Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment
    Helen L Storr
    Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 88:34-7. 2003
    ..GH deficiency occurred in 86% patients. Long-term follow-up suggests some recovery of GH secretion and preservation of other anterior pituitary function...
  26. ncbi A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children
    Marta Korbonits
    Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 87:4005-8. 2002
    ..These data suggest that variations in the ghrelin gene contribute to obesity in children and may modulate glucose-induced insulin secretion...
  27. ncbi Role of regulatory factors in pituitary tumour formation
    Marta Korbonits
    Department of Endocrinology, St Bartholomew s Hospital, London, UK
    Front Horm Res 32:63-95. 2004
    ....
  28. ncbi Ghrelin--a hormone with multiple functions
    Marta Korbonits
    Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, UK
    Front Neuroendocrinol 25:27-68. 2004
    ..Increasing data link ghrelin to the overall control of energy use and flow in situations where there is a limitation of energy sources and ghrelin appears to play a pivotal role in energy homeostasis...
  29. ncbi CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome
    Andrea G Rockall
    Department of Academic Radiology, St Bartholomew s Hospital, Dominion House, St Bartholomew s Close, London EC1A 7ED, England
    Radiographics 24:435-52. 2004
    ..Familiarity with the range of imaging appearances of the adrenal glands in primary adrenal Cushing syndrome may help establish the underlying diagnosis...
  30. ncbi The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors
    Madalina Musat
    Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, UK
    Pituitary 5:235-42. 2002
    ..Our data suggest that increased p27 degradation through the ubiquitin-proteasome pathway could be regulated in pituitary tumors by changes in Skp2 expression, although other factors probably also play a role...
  31. ncbi The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans
    Sharmilee Gnanapavan
    Department of Endocrinology, St Bartholomew s and The Royal London Hospital, London ECIA 7BE, UK
    J Clin Endocrinol Metab 87:2988. 2002
    ..These data suggest that ghrelin might have widespread physiological effects via different, partly unidentified, subtypes of the GHS-R in endocrine and non-endocrine tissues...
  32. ncbi Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer
    Dorota Dworakowska
    Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Poland
    Lung Cancer 66:127-33. 2009
    ..04). This study demonstrates that joint analysis of several factors involved in apoptosis, proliferation and cell cycle regulation, but not AI alone, might provide additional prognostic information in NSCLC patients...
  33. ncbi The diagnosis and medical management of advanced neuroendocrine tumors
    Gregory A Kaltsas
    Department of Endocrinology, St Bartholomew's Hospital, London EC1A 7BE, United Kingdom
    Endocr Rev 25:458-511. 2004
    ..Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival...
  34. ncbi The expression of ghrelin O-acyltransferase (GOAT) in human tissues
    Chung Thong Lim
    Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom
    Endocr J 58:707-10. 2011
    ..Identification of GOAT expression in various tissues support the concept that in addition to the important endocrine effect of acylated ghrelin, the paracrine effects of locally synthetised and acylated ghrelin may be important...
  35. ncbi Androgen- and estrogen-secreting adrenal cancers
    Dominic Cavlan
    Department of Endocrinology, Barts and The London NHS Trust, London, UK
    Semin Oncol 37:638-48. 2010
    ..The most reliable indicator of malignancy in these tumors remains the presence of metastases. Treatment is essentially surgical, although the role of mitotane is one undergoing evaluation...
  36. ncbi Examining the candidacy of ghrelin as a gene responsible for variation in adult stature in a United Kingdom population with type 2 diabetes
    Maria Gueorguiev
    Reader in Endocrine Research, Department of Endocrinology, Room 114C, John Vane Science Centre, Barts and the London Medical School, Charterhouse Square, London, UK
    J Clin Endocrinol Metab 92:2201-4. 2007
    ..Recently, a quantitative trait locus for stature was reported on chromosome 3p26 in patients with type 2 diabetes...
  37. ncbi Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas
    Damian G Morris
    Department of Endocrinology, St Bartholomew s Hospital, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 88:6080-7. 2003
    ....
  38. ncbi Protein western array analysis in human pituitary tumours: insights and limitations
    Antônio Ribeiro-Oliveira
    Department of Endocrinology, Barts and the London School of Medicine and Dentistry, London EC1M 6BQ, UK
    Endocr Relat Cancer 15:1099-114. 2008
    ..Protein expression analysis of pituitary samples disclosed both novel proteins and putative protein candidates for pituitary tumorigenesis, though validation using conventional techniques are necessary to confirm the protein array data...
  39. ncbi Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome
    Blerina Kola
    Centre for Endocrinology, John Vane Science Centre, Barts and the London School of Medicine and Dentistry, London EC1M 6BQ, United Kingdom
    J Clin Endocrinol Metab 93:4969-73. 2008
    ..In the current study, we demonstrate the effect of high glucocorticoid levels on AMPK activity of human adipose tissue samples from patients with Cushing's syndrome...
  40. ncbi Expanding role of AMPK in endocrinology
    Blerina Kola
    Department of Endocrinology, Barts and The London, Queen Mary's School of Medicine and Dentistry, University of London, London, EC1M 6BQ, UK
    Trends Endocrinol Metab 17:205-15. 2006
    ..Recent studies have illustrated the interaction between hormones and AMPK, and highlighted AMPK as a potential target for the development of tissue-specific AMPK modulators in the treatment of obesity and the metabolic syndrome...
  41. ncbi Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours
    Erika Hubina
    Department of Endocrinology, William Harvey Research Institute, Barts and the London Medical School, Queen Mary College, Charterhouse Square, London EC1M 6BQ, UK
    Eur J Endocrinol 155:371-9. 2006
    ..More potent and broader-spectrum SST analogues are likely to play an increasing role in the treatment of tumours, where the MAP kinase pathway is overactivated...
  42. ncbi Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours
    Gregory A Kaltsas
    Department of Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, UK
    Clin Endocrinol (Oxf) 57:443-8. 2002
    ..Relative mRNA expression was not decreased in any of the sporadic pituitary tumour samples. The present data thus do not suggest a major role for the PRKAR1A tumour suppressor gene in sporadic GH-secreting or other pituitary tumours...
  43. ncbi Imaging in covert ectopic ACTH secretion: a CT pictorial review
    Paul A Sookur
    Department of Academic Radiology, Dominion House, St Bartholomew s Hospital, West Smithfield, London, EC1A 7BE, UK
    Eur Radiol 19:1069-78. 2009
    ..Awareness of the imaging characteristics will aid identification of the source of ACTH production and allow potentially curative surgical resection...
  44. ncbi Differential gene expression in pituitary adenomas by oligonucleotide array analysis
    Damian G Morris
    Department of Endocrinology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK
    Eur J Endocrinol 153:143-51. 2005
    ..CONCLUSIONS: Expression array analysis of pituitary adenomas using the Affymetrix GeneChip HG-U133A arrays appears to be a valid method of identifying genes that may be important in tumour pathogenesis...
  45. ncbi Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas
    Y Sammy Woo
    Department of Endocrinology, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 90:4963-9. 2005
    ..Few patients with macroadenomas were cured by surgery. CONCLUSIONS: Pituitary macroadenomas causing Cushing's disease have biochemical features largely distinct from patients harboring microadenomas but represent one end of a continuum...
  46. ncbi The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas)
    Gregory A Kaltsas
    Department of Endocrinology, St. Bartholomew's Hospital, London, UK
    Front Horm Res 31:61-75. 2004
  47. ncbi Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors
    Hiu Yan Chan
    Barts and the London School of Medicine, London, UK
    Adv Ther 27:495-511. 2010
    ....
  48. ncbi The role of AMP-activated protein kinase in obesity
    Blerina Kola
    Department of Endocrinology, Barts and The London, Queen Mary s School of Medicine and Dentistry, University of London, London, UK
    Front Horm Res 36:198-211. 2008
    ..Whether AMPK changes are one of the causes or the consequence of these pathological conditions remains a matter of debate, but AMPK clearly represents a major potential pharmacological target in the treatment of these conditions...
  49. ncbi Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families
    Susana Igreja
    Department of Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom EC1M 6BQ
    Hum Mutat 31:950-60. 2010
    ..Functional characterization of AIP changes is important to identify the functional impact of gene sequence variants...
  50. ncbi Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation
    Maralyn R Druce
    Department of Endocrinology, Barts and the London Medical School, St Bartholomew s Hospital, London, UK
    Eur J Endocrinol 162:971-8. 2010
    ..Preoperative localisation of insulinoma improves cure rate and reduces complications, but may be challenging...
  51. ncbi The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes
    Edwin A Garcia
    Department of Endocrinology, Barts and London School of Medicine and Dentistry, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK
    Eur J Endocrinol 161:307-15. 2009
    ..Ghrelin and its receptor play an important role in glucose metabolism and energy homeostasis, and therefore they are functional candidates for genes carrying susceptibility alleles for type 2 diabetes...
  52. ncbi Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome
    Andrea M Isidori
    Department of Endocrinology, St. Bartholomew's Hospital, London ECIA 7BE, United Kingdom
    J Clin Endocrinol Metab 88:5299-306. 2003
    ..There does not appear to be any necessity for retaining the high-dose dexamethasone suppression test in this diagnostic work-up...
  53. ncbi AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome
    Mirjam Christ-Crain
    Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine, London EC1M 6BQ, UK
    FASEB J 22:1672-83. 2008
    ..Our data suggest that metformin treatment could be effective in preventing the metabolic complications of chronic glucocorticoid excess...
  54. ncbi Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma
    Anthony P Goldstone
    Department of Endocrinology, St Bartholomew s Hospital, London, United Kingdom
    J Clin Endocrinol Metab 90:2681-90. 2005
    ....
  55. ncbi Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis
    Helen L Storr
    Department of Endocrinology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, West Smithfield, London, United Kingdom EC1A 7BE
    J Clin Endocrinol Metab 89:3818-20. 2004
    ..In conclusion, female preponderance of CD in adult patients was not present in childhood. In patients 18 yr of age or younger, there was no difference in the severity of hypercortisolemia or ACTH at diagnosis between males and females...
  56. ncbi CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas)
    Anju Sahdev
    Department of Radiology, St Bartholomew s Hospital, West Smithfield, London, EC1A 7BE, UK
    Eur Radiol 15:85-92. 2005
    ....
  57. ncbi Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway
    Alexandra M Nanzer
    Department of Endocrinology, St Bartholomew s Hospital, 59 Bartholomew Close, Unit 1 1, London EC1A 7BE, UK
    Eur J Endocrinol 151:233-40. 2004
    ..However, ghrelin has also been shown to have anti-proliferative effects on breast, lung and thyroid cell lines. We therefore examined the effect of ghrelin on the rat pituitary cell line GH3...
  58. ncbi Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance
    Anthony P Goldstone
    Department of Endocrinology, St Bartholomew s Hospital, London, United Kingdom EC1A 7BE
    J Clin Endocrinol Metab 89:1718-26. 2004
    ..The hyperghrelinemia in PWS adults is therefore not solely explained by their reduced visceral adiposity and relative hypoinsulinemia. Its cause and consequences await further elucidation...
  59. ncbi Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
    Gregory Kaltsas
    Department of Endocrinology, St Bartholomew's Hospital, London ECIA 7BE, UK
    Eur J Endocrinol 151:15-27. 2004
    ....
  60. ncbi Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
    Dorota Dworakowska
    Barts and the London School of Medicine, Centre for Endocrinology, London EC1M 6BQ, UK
    Endocr Relat Cancer 16:45-58. 2009
    ....
  61. ncbi Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis
    Maria Gueorguiev
    Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK
    Pituitary 12:245-55. 2009
    ..We review and assess the role of the beta-catenin signaling pathway in the pathogenesis of pituitary adenomas...
  62. ncbi Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
    Simona Grozinsky-Glasberg
    Barts and the London School of Medicine, Centre for Endocrinology, University of London, London EC1M 6BQ, UK
    Endocr Relat Cancer 15:701-20. 2008
    ..The development of new SSA, new drug combination therapies and chimaeric molecules should further improve the clinical management of these patients, as should a more complete understanding of their mode of action...
  63. ncbi Dynamic testing in Cushing's syndrome
    Blerina Kola
    Department of Endocrinology, Barts and The London, Queen Mary s School of Medicine, University of London, London, UK
    Pituitary 11:155-62. 2008
    ..The biochemical results should be interpreted jointly with the clinical aspects and the radiology findings in a probabilistic matrix, and not as part of a uniform algorithm...
  64. ncbi 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation
    Kunwar S S Bhatia
    Department of Academic Radiology, St Bartholomew s Hospital, London, UK
    Clin Endocrinol (Oxf) 69:181-8. 2008
    ..Evidence regarding the accuracy of [(123)I] metaiodobenzylguanidine (MIBG) imaging for phaeochromocytoma localization is currently limited to small series...
  65. ncbi Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia
    Partha Kar
    Department of Medicine, Great Western Hospital, Swindon, UK
    J Clin Endocrinol Metab 91:4733-6. 2006
    ..CONCLUSIONS: Although the sensitivity of the 72-h fast is high and still plays an important role in the diagnosis of an insulinoma, we suggest that a "normal" test result should be interpreted in the light of clinical symptoms...
  66. ncbi Retinoic acid as a novel medical therapy for Cushing's disease in dogs
    Victor Castillo
    , Hospital Escuela, Facultad de Ciencias Veterinarias, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina
    Endocrinology 147:4438-44. 2006
    ..This study highlights the possibility of using retinoic acid as a novel therapy in the treatment of ACTH-secreting tumors in humans with Cushing's disease...
  67. ncbi The diagnosis and management of malignant phaeochromocytoma and paraganglioma
    Alexandra Chrisoulidou
    Department of Endocrinology and Endocrine Oncology, Theagenion Hospital, Thessaloniki, Greece
    Endocr Relat Cancer 14:569-85. 2007
    ..Ongoing microarray studies may provide novel intracellular pathways of importance for proliferation/cell cycle control, and lead to the development of novel pharmacological agents...
  68. ncbi The optimal imaging of adrenal tumours: a comparison of different methods
    Ioannis Ilias
    Department of Endocrinology, Elena Venizelou Hospital, Athens GR 11521, Greece
    Endocr Relat Cancer 14:587-99. 2007
    ..Adrenal imaging complements and assists the clinical and hormonal evaluation of adrenal tumours...
  69. ncbi Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical center
    Shabin M Joshi
    Department of Neurosurgery, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, England
    Neurosurgery 57:281-5; discussion 281-5. 2005
    ..We found the use of intraoperative neuronavigation to be an excellent aid in overcoming such anatomic difficulties...
  70. ncbi Osteoporosis in Cushing's syndrome
    Gregory Kaltsas
    Department of Endocrinology, St Bartholomew's Hospital, London, UK
    Front Horm Res 30:60-72. 2002
  71. ncbi Pituitary-targeted medical therapy of Cushing's disease
    Krystallenia I Alexandraki
    Professor of Neuroendocrinology St Bartholomew s Hospital, Ashley Grossman FMedSci, London EC1A 7BE, UK
    Expert Opin Investig Drugs 17:669-77. 2008
    ..However, no effective drug that directly and reliably targets the adrenocorticotropin-secreting pituitary adenoma has yet been found...
  72. ncbi Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase
    Blerina Kola
    Department of Endocrinology, William Harvey Research Institute, Barts and the London Medical School, London EC1M 6BQ, United Kingdom
    J Biol Chem 280:25196-201. 2005
    ..Our data demonstrate that AMPK not only links the orexigenic effects of endocannabinoids and ghrelin in the hypothalamus but also their effects on the metabolism of peripheral tissues...
  73. ncbi A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia
    Farideh Miraki-Moud
    Department of Endocrinology, 51-53 Bartholomew Close, St. Bartholomew's Hospital, London EC1A 7BE, United Kingdom
    J Clin Endocrinol Metab 90:3819-23. 2005
    ....
  74. ncbi Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line
    Simona Grozinsky-Glasberg
    Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine and Dentistry, University of London, London, UK
    Neuroendocrinology 87:168-81. 2008
    ..We explored the mechanism of action of octreotide, RAD001, and their combination on cell proliferation and kinase activation in a neuro-endocrine tumour cell line (rat insulinoma cell line, INS1)...
  75. ncbi The heme oxygenase-carbon monoxide pathway in the control of neuroendocrine function
    Pierluigi Navarra
    Institute of Pharmacology, Catholic University Medical School, Rome, Italy
    Front Horm Res 29:108-16. 2002
  76. ncbi The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful?
    Ashley B Grossman
    Acta Neuropathol 111:76-7. 2006
  77. ncbi Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease
    C Megan Ogilvie
    Department of Endocrinology, St. Bartholomew's Hospital, London, EC1A 7BE, UK
    Pituitary 8:139-46. 2005
    ..This is an important diagnosis to make as rapidly as possible to allow the early institution of effective therapy...
  78. ncbi Cushing's syndrome
    John Newell-Price
    Division of Clinical Sciences, University of Sheffield, Northern General Hospital, Sheffield, UK
    Lancet 367:1605-17. 2006
    ..Here, we review the current understanding of pathogenesis, clinical features, diagnostic, and differential diagnostic approaches. We provide diagnostic algorithms and recommendations for management...
  79. ncbi The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system
    Blerina Kola
    Department of Endocrinology, Barts and the London School of Medicine and Dentistry, University of London, United Kingdom
    PLoS ONE 3:e1797. 2008
    ..The cannabinoid receptor type 1 (CB1) antagonist rimonabant can block the orexigenic effect of ghrelin. In this study, we have elucidated the mechanism of the putative ghrelin-cannabinoid interaction...
  80. ncbi Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005
    Karel Pacak
    National Institute of Child Health and Development, NIH, Bethesda, MD, USA
    Nat Clin Pract Endocrinol Metab 3:92-102. 2007
    ..Inadequate methods to distinguish malignant from benign tumors and a lack of effective treatments for malignancy are important problems requiring further resolution...
  81. ncbi Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances
    Helen L Storr
    Department of Endocrinology, William Harvey Research Institute, Barts and The London, Queen Mary s School of Medicine and Dentistry, John Vane Science Centre, Charterhouse Square, London, EC1M 6BQ, UK
    Trends Endocrinol Metab 18:167-74. 2007
    ..The management of paediatric CS patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life...
  82. ncbi Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator
    Nikolai Petrovsky
    Autoimmunity Research Unit, The Canberra Hospital, John Curtin School of Medical Research, Australian National University, Canberra, Australia
    Immunol Cell Biol 81:137-43. 2003
    ..These observations explain the beneficial role of macrophage migration inhibitory factor neutralization in models of inflammatory arthritis...
  83. ncbi Adrenal incidentalomas: 'the rule of four'
    Krystallenia I Alexandraki
    Department of Endocrinology, St Bartholomew's Hospital, London
    Clin Med 8:201-4. 2008
  84. ncbi Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility
    Dewi Astuti
    Section of Medical and Molecular Genetics, Department of Paediatrics and Child Health, University of Birmingham, Edgbaston, Birmingham, UK
    Clin Endocrinol (Oxf) 59:728-33. 2003
    ..CONCLUSION: The significantly lower frequency (P = 0.028) of germline SDH subunit mutations in familial PC only cases compared to those with familial PC and HNPGL suggests that further PC susceptibility gene(s) remain to be identified...